ESLA — Estrella Immunopharma Balance Sheet
0.000.00%
Last trade - 00:00- $49.84m
- $27.70m
- 49
- 22
- 10
- 16
Annual balance sheet for Estrella Immunopharma, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | 10-K | 10-K | |
| Standards: | — | USG | USG |
| Status: | fx Preliminary | Final | Final |
| Cash | |||
| Cash and Short Term Investments | — | 0.479 | 0.041 |
| Prepaid Expenses | |||
| Total Current Assets | — | 0.616 | 0.052 |
| Long Term Investments | |||
| Total Assets | — | 45.8 | 9.72 |
| Payable / Accrued | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | — | 0.073 | 1.07 |
| Total Long Term Debt | |||
| Total Debt | |||
| Deferred Income Tax | |||
| Total Other Liabilities | |||
| Total Liabilities | — | 1.62 | 2.65 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | — | 44.2 | 7.07 |
| Total Liabilities & Shareholders' Equity | — | 45.8 | 9.72 |
| Total Common Shares Outstanding |